Literature DB >> 1159504

In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration.

I R McDougall, J K Dunnick, M L Goris, J P Kriss.   

Abstract

The in vivo distribution of vesicles containing radiopharmaceuticals in their cavities has been studied using three routes of administration: intravenous, subcutaneous, and intraperitoneal. The in vivo distribution in mice was determined by dissection of the animals and calculation of radioactivity in the organs. In rats the in vivo distribution was assessed by scintigraphy using a scintillation camera-digital computer unit. After intravenous injection of vesicles, radioactivity is concentrated to some extent in the liver and spleen but the pattern of distribution is different from that of the corresponding free radiopharmaceutical or radiocolloid made of the corresponding radionuclide. The permeability of the vesicular membrane to contained radiopharmaceutical has been shown to vary according to the chemical composition of the vesicles. Vesicles can be used to introduce materials in vivo and the potential exists for their specific targeting by coupling other molecules to their surfaces.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159504

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Stability of lipid vesicles in tissues of the mouse: a gamma-ray perturbed angular correlation study.

Authors:  M R Mauk; R C Gamble
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

2.  Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers.

Authors:  A Sharma; N L Straubinger; R M Straubinger
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

3.  Synthesis of neoglycopeptides and analyses of their biodistribution in vivo to identify tissue specific uptake and novel putative membrane lectins.

Authors:  D Gupta; A Surolia
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

4.  Altered pharmacological properties of liposome-associated human interferon-alpha.

Authors:  D A Eppstein; W E Stewart
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice.

Authors:  M R Mauk; R C Gamble; J D Baldeschwieler
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

6.  Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles.

Authors:  Víctor M Blanco; Zhengtao Chu; Kathleen LaSance; Brian D Gray; Koon Yan Pak; Therese Rider; Kenneth D Greis; Xiaoyang Qi
Journal:  Oncotarget       Date:  2016-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.